Showing 91-100 of 3260 results for "".
Addressing the Unique Challenges of AD Patients
https://practicaldermatology.com/series/c-suite-chats/addressing-the-unique-challenges-of-ad-patients/28617/Patrick Burnett, MD, PhD, Chief Medical Officer at Arcutis Bioteheraputics, discusses the promise of the company’s roflumilast cream for AD.EBD Insights
https://practicaldermatology.com/conferences/maui-derm-2022/ebd-insights/20049/There are a number of new and reliable energy-based devices available. Michael H. Gold, MD discusses tried-and-true technologies as well as new and innovative devices that offer efficacious options on the market for a variety of dermatologic needs.Exploring High-Dose Neurotoxin Injections
https://practicaldermatology.com/conferences/maui-derm-2022/exploring-high-dose-neurotoxin-injections/20055/Michael H. Gold, MD shares his thoughts on the potential benefits of high-dose neurotoxin injections for some patients. He discusses his experience and the kind of results he's been able to achieve.EBDs and the Shape of Things to Come
https://practicaldermatology.com/conferences/asds-2021/ebds-and-the-shape-of-things-to-come/20019/Demand for procedures to tighten and tone continues to grow, and technology continues to evolve to meet patient demands. Michael H. Gold, MD discusses new and emerging energy-based devices that may improve outcomes and the patient experience.Skin Care for All
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/skin-care-for-all/19708/Every patient gets skin care, says Michael Gold, MD, who says that a number of good products are now on the market. He identifies some leading formulations.What Dermatologists Ought to Know About Cyspera®
https://practicaldermatology.com/topics/general-topics/what-dermatologists-ought-to-know-about-cyspera/20103/Cyspera has become a "go-to topical product for pigment," says Michael H. Gold, MD. He describes the Cyspera Intensive System and its benefits for the management of hyperpigmentation. He discusses advancements in the Cyspera formulation that enhance outcomes.Derm 2020: What’s New and in the Pipeline
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/derm-2020-whats-new-and-in-the-pipeline/19742/Michael Gold, MD shares insights on advances in aesthetic and medical dermatology, from novel devices to a new acne combination treatment being studied to skincare products, toxins and fillers coming to the US market.Energy-based Devices for Fat Reduction
https://practicaldermatology.com/conferences/maui-derm-2024/energy-based-devices-for-fat-reduction/20236/Michael H. Gold, MD, founder and medical director of the Gold Skin Care Center in Nashville, highlights new energy-based devices for fat reduction, including those utilizing lasers and radio frequency technology for muscle stimulation.SCALE 2019: Meeting Highlights from Music City
https://practicaldermatology.com/topics/practice-management/scale-2019-meeting-highlights-from-music-city/19619/With an emphasis on both medical and cosmetic dermatology as well as practice management, Music City Scale or the Symposium for Cosmetic Advances and Laser Education has something for everyone, organizers says. Co-chairs Michael Gold, MD and Brian Biesman, MD are joined by several presenters to discHilary Baldwin, MD: Perspective on the FDA Citizen's Petition for Acne Products with Benzoyl Peroxide (BPO)
https://practicaldermatology.com/topics/acne-rosacea/hilary-baldwin-md-perspective-fda-citizens-petition-acne-products-benzoyl-peroxide-bpo/24171/Neal Bhatia, MD, chief medical editor of Practical Dermatology® talks to Hilary E. Baldwin, MD about a new report from an independent laboratory that finds benzene can form at unacceptably high levels in both over-the-counter and prescription medications that contain benzoyl peroxide.